Andreas Cerny
Lugano, TI, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Transarterial Chemoembolization in Hepatocellular Carcinoma: Lessons from a 10-Year Real-World Retrospective Study.
Journal: Journal of hepatocellular carcinoma
Published: January 25, 2026
Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis.
Journal: European journal of gastroenterology & hepatology
Published: July 22, 2025
SARS-CoV-2 mRNA vaccines do not worsen autoimmunity in patients with autoimmune liver diseases.
Journal: Journal of autoimmunity
Published: July 14, 2024
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.
Journal: Swiss medical weekly
Published: December 19, 2023
Response to "Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'".
Journal: Journal of viral hepatitis
Published: November 03, 2023
Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
Journal: Swiss medical weekly
Published: September 28, 2023
Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial.
Journal: Journal of viral hepatitis
Published: July 19, 2023
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.
Journal: JHEP reports : innovation in hepatology
Published: July 11, 2022
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
Journal: Journal of autoimmunity
Published: June 26, 2021
Safety of mRNA-Based Vaccines for SARS CoV-2.
Journal: Chemical research in toxicology
Published: May 19, 2021
Last Updated: 09/26/2026